Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Pfizer Inc.
Sort By
Newest First
1 / 5
M&A
Novo Holdings Portfolio Company ReViral to be Acquired by Pfizer
Novo Holdings A/S
PR-M04-22-05
Apr 07, 2022
COVID-19 Vaccine
Pfizer and BioNTech to Vaccinate Olympic Athletes in Tokyo
Pfizer
PR-M05-21-014
May 20, 2021
Emergency Use
Pfizer and BioNtech Receive First U.S. Authorization for Emergency Use of Covid-19 Vaccine in Adolescents
Pfizer
PR-M05-21-007
May 11, 2021
COVID-19
Pfizer and BioNTech Announce Vaccine Candidate Against COVID-19 Achieved Success in First Interim Analysis from Phase 3 Study
Pfizer
PR-M11-20-007
Nov 10, 2020
COVID-19 Vaccine
Pfizer and BioNTech Announce Data from Preclinical Studies of COVID-19 Vaccine Candidate
Pfizer
PR-M09-20-NI-15
Sep 11, 2020
Agreement
PPD Signs New Service Agreement with Pfizer
PPD, part of Thermo Fisher Scientific
PR-M08-20-NI-08
Aug 04, 2020
COVID-19 Vaccine
Pfizer and BioNTech to Receive $2 Billion from U.S. Government
Pfizer
PR-M07-20-NI-33-1383
Jul 23, 2020
COVID-19 Vaccine
Pfizer and BioNTech Report T Cell Response in COVID-19 Vaccine
Pfizer
PR-M07-20-NI-30
Jul 21, 2020
COVID-19 Vaccine
Pfizer and BioNTech Announce Early Positive Data from an Ongoing Phase 1/2 Study of mRNA-based Vaccine Candidate Against SARS-CoV-2
Pfizer
PR-M06-20-NI-042
Jul 02, 2020
Investment
Pfizer Establishes New Program to Support Continued Biotechnology Innovation
Pfizer
PR-M06-20-NI-001
Jun 02, 2020
Medical Professionals Across Merck, Pfizer, and Eli Lilly Volunteer Amid COVID-19 Pandemic
Eli Lilly and Company
PR-M04-20-NI-004
Apr 02, 2020
M&A
Mylan and Pfizer Provide Update Regarding Proposed Combination of Mylan and Upjohn
Mylan
PR-M03-20-NI-041
Mar 26, 2020
Vaccine
Pfizer and BioNTech to Co-develop Potential COVID-19 Vaccine
BioNTech
PR-M03-20-NI-031
Mar 20, 2020
Artificial Intelligence
Insilico Enters into Artificial Intelligence Collaboration with Pfizer
Insilico Medicine
PR-M01-20-NI-029
Jan 17, 2020
Drug Pricing
Gene Therapy Payment Questions Linger
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-M11-19-NI-003
Nov 12, 2019
Licensing Agreement
Akcea and Pfizer Inc. Announce Licensing Agreement for Investigative Antisense Therapy Akcea-ANGPTL3-LRX
Pfizer
PR-M10-19-NI-020
Oct 11, 2019
Leadership
Ian Read to Retire as Executive Chairman of Pfizer’s Board of Directors; Chief Executive Officer Dr. Albert Bourla Named Chairman
Pfizer
PR-M09-19-NI-053
Sep 27, 2019
Vaccine
Pfizer Announces Positive Preliminary Results from a 2 Study of its 20-Valent Pneumococcal Conjugate Vaccine Candidate for Disease Prevention in Infants
Pfizer
PR-M09-19-NI-028
Sep 11, 2019
Investment
The Pfizer Foundation Invests in 20 Organizations Tackling Infectious Diseases and Antimicrobial Resistance
The Pfizer Foundation
PR-M08-19-NI-072
Aug 26, 2019
Recall
Pfizer Inc. Issues A Voluntary Nationwide Recall For 2 Lots of RELPAX® Due to Potential Microbiological Contamination of Non-Sterile Product
Pfizer
PR-M08-19-NI-048
Aug 16, 2019
1 / 5
